Clinical Trial Update: A Trial of DB289 for the Treatment of Stage I African Trypanosomiasis [Phase 2]

View source ↗

Summary

A Phase 2 trial of DB289 for Stage I African trypanosomiasis sponsored by Immtech Pharmaceuticals has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human African Trypanosomiasis

Drugs mentioned

• DB289

Snippet

Sponsor: Immtech Pharmaceuticals, Inc | Conditions: Trypanosomiasis, African | Phase 2 | Status: COMPLETED